Navigation Links
Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
Date:12/2/2008

Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses. Research to be presented at the 57th American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting in New Orleans, explains how vaccines and drugs may not only be able to stop disease transmission, but also prematurely kill the vectors carrying these diseases; such vectors include ticks, sand flies and mosquitoes the insects responsible for most deaths world wide.

"In order to successfully slow the transmission rate of these potentially fatal diseases, we need to reduce the lifespan of the vector, or block them from becoming infected in the first place," explains Brian Foy, Ph.D., at Colorado State University. "One of our goals is to curtail the spread of mosquito-borne diseases through strategic use of compounds, known as endectocides, to target hosts. This new strategy will make blood meals from humans lethal to mosquitoes so they die before they can transmit a disease." Endectocides are currently mass administered to human populations to control the worm parasites that cause river blindness and are widely used in animals for worm control.

Professor Foy says that thanks to new technologies using genomics, scientists can now sift through vector genomes to more quickly and accurately find protein targets, which can then aid in the development of more specified drugs and vaccines.

A vaccine developed using functional genomics is already in early stages for cattle, whose production is greatly affected by tick-borne diseases. Katherine Kocan, Ph.D., at Oklahoma State University, concentrates her research on tick vaccines and anaplasmosis, a tick-transmitted disease of cattle that infects the red blood cells, cau
'/>"/>

Contact: Jennifer Bender
jbender@environics-usa.com
203-325-8772
American Society of Tropical Medicine and Hygiene
Source:Eurekalert

Page: 1 2

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... France, Nov. 27 Team Garmin-Slips...m dedicated to ethical sporting and developing the...oday that it will become Team Garmin-Transitions w...ponsor of the team. Transitions Optical is the wor...ering the most advanced photochromic technology in...
(Date:11/27/2009)...nted medical, economic burdens, study predicts , ... number of people with diabetes in the United Stat... new study predicts. , That would bring the tot...isease, up from 23.7 million today. , , At the s...s will triple, the study also warns, rising from a...
(Date:11/27/2009)...list manufacturers who use medical load cells at t...dollars by bringing in technology partner Flintec ... pro-active medical manufacturers are calling in F...heir projects, ensuring that progress will not be ...ially outdated technology. , ...
(Date:11/26/2009)...er of Americans living with diabetes will nearly d...1 million in 2034. Over the same period, spending ...illion to $336 billion, even with no increase in t... University of Chicago report in the December issu... diabetes covered by Medicare will rise from 8.2 m...
(Date:11/26/2009)...e letters from the North Pole, Textsanta.net lets ...m Santa , North Pole, AK ...ficiencies at the North Pole Santa Claus has added... the globe informed of his Christmas progress at t... department have identified a large and growing pe...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
... announced a,partnership with leading breast care ... These Centers, including breast care physicians f...rship with Sanarus to,increase the awareness and a... of these new Centers prior to,the American Colleg...
...tion on the reauthorization of the State Children,...uld set SCHIP on a solid path over the next,10 yea... Georgetown,University Center for Children and Fam...,CCF analysis, Summary of The Children,s Health In...
...atives International, Inc. ("NAI") (Nasdaq: NAII ... of customized nutritional,supplements, today anno...on,Form 10-K for the fiscal year ended June 30, 20...Form 10-K no later than,October 15, 2007. While N...
...olytics Biotech Inc. (Oncolytics) (TSX:ONC, NASDAQ...g interim results from a U.K. Phase Ia/Ib combina...ients with advanced or metastatic cancers is sched...ological Approaches to Radiosensitisation: Viruses...
...e, study finds , , FRIDAY, Sept. 28 (Healt...weight as a direct cause of high blood pressure. A...ople can bring down blood pressure to healthy leve...sor of medicine at the University of Pavia. He was...
...ia (compulsive hair-pulling) affects between 2-4 %...ildren -- yet remains little,known or understood b...e,Trichotillomania Learning Center (TLC) is drawin... 2007 events include: screenings of the award-winn...
Other Medicine News:Health News:Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas 2Health News:CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path 2Health News:Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008 2Health News:Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008 3Health News:Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials 2Health News:Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials 3Health News:Weight Loss Can Control Hypertension 2Health News:Weight Loss Can Control Hypertension 3Health News:National Trichotillomania Awareness Week Gives Help and Hope to Hair-Pullers 2
(Date:11/25/2009)...N, Fla., Nov. 25 Ameri...("the Company") is pleased to announce that they h...agement office in Shanghai, China. ,, ASR has b... essential gateway for the development and product...ts for children and adults to be distributed and s...
(Date:11/25/2009)...ADELPHIA, Nov. 25 ERT (N.... McKelvey, the Company,s President and CEO, and K...nt and CFO, are scheduled to present at the 21st A... PM EST on December 1, 2009 in New York City, New ...entation by visiting the Company,s corporate websi...
(Date:11/25/2009)...LM BEACH, Fla., Nov. 25 ...cans, especially the 27 million living with untrea...at happy, says audiologist Cindy Beyer. ,, Dr. ...R ), one of America,s largest hearing care and he...aring loss to stress, frustration, and social isol...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3INHS Brings Health Information Technology Conference to Spokane 52550 1INHS Brings Health Information Technology Conference to Spokane 52550 2Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 1Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 2Bioheart Announces Acceptance of Marvel 1 Data for Presentation at the Heart Failure Society of America 28HFSA 29 Meeting 52545 3Risky driving puts P platers at high danger of crash 52541 1Risky driving puts P platers at high danger of crash 52541 2
...aceuticals,Inc. (Nasdaq: ARNA ) announced today t...e overview of its clinical development and discove... -- ThinkEquity Partners, 5th Annual Growth Confe... at 10:00 a.m. Pacific Time (1:00 p.m. Eastern... Presenting: Jack Lief, Arena,s President and Chie...
... Liver Cancer Conference Sta...y Consulting Firm Retained, NOVATO, Calif., Sept.... "Company") (OTC Bulletin Board:,RPTP.OB) announce...Scientific Officer, will present a poster detailin...al studies of its HepTide(TM) liver targeting,prog...
Other Medicine Technology:Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences 3Raptor Pharmaceuticals Provides Update of Product Programs 2Raptor Pharmaceuticals Provides Update of Product Programs 3Raptor Pharmaceuticals Provides Update of Product Programs 4Raptor Pharmaceuticals Provides Update of Product Programs 5Raptor Pharmaceuticals Provides Update of Product Programs 6
The Natural-Hip Family - Specialty Porous collarless HA
The Natural-Hip Family - High Demand Porous (collared)
The APR Hip Family - Nonporous Fully Textured The Cost-Conscious Stem
The APR Hip Family - Porous (collared)
Medicine Products: